These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7603807)

  • 41. Seven days vs. 10 days ceftriaxone therapy in bacterial meningitis.
    Singhi P; Kaushal M; Singhi S; Ray P
    J Trop Pediatr; 2002 Oct; 48(5):273-9. PubMed ID: 12405169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of steroids in the management of children with bacterial meningitis.
    Prober CG
    Pediatrics; 1995 Jan; 95(1):29-31. PubMed ID: 7770304
    [No Abstract]   [Full Text] [Related]  

  • 43. The role of corticosteroid therapy in children with pneumococcal meningitis.
    Kennedy WA; Hoyt MJ; McCracken GH
    Am J Dis Child; 1991 Dec; 145(12):1374-8. PubMed ID: 1669663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of Hippocampal Regeneration by Adjuvant Dexamethasone in Experimental Infant Rat Pneumococcal Meningitis.
    Bally L; Grandgirard D; Leib SL
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1841-6. PubMed ID: 26824948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacterial meningitis: still a cause of high mortality and severe neurological morbidity in childhood.
    Daoud AS; al-Sheyyab M; Batchoun RG; Rawashdeh MO; Nussair MM; Pugh RN
    J Trop Pediatr; 1995 Oct; 41(5):308-10. PubMed ID: 8531266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Corticosteroids for acute bacterial meningitis.
    van de Beek D; de Gans J; McIntyre P; Prasad K
    Cochrane Database Syst Rev; 2007 Jan; (1):CD004405. PubMed ID: 17253505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of effectiveness of dexamethasone in neonatal bacterial meningitis.
    Daoud AS; Batieha A; Al-Sheyyab M; Abuekteish F; Obeidat A; Mahafza T
    Eur J Pediatr; 1999 Mar; 158(3):230-3. PubMed ID: 10094445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjunctive dexamethasone therapy in unconfirmed bacterial meningitis in resource limited settings: is it a risk worth taking?
    Gudina EK; Tesfaye M; Adane A; Lemma K; Shibiru T; Wieser A; Pfister HW; Klein M
    BMC Neurol; 2016 Aug; 16(1):153. PubMed ID: 27561331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjunctive corticosteroid therapy in bacterial meningitis.
    Lauritsen A; Oberg B
    Scand J Infect Dis; 1995; 27(5):431-4. PubMed ID: 8588129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Role of corticoids in purulent meningitis in children: analysis of literature studies].
    Jacqz-Aigrain E; Guillonneau M
    Arch Pediatr; 1997 Jan; 4(1):52-60. PubMed ID: 9084710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective investigation of the long-term auditory-neurological sequelae associated with bacterial meningitis: a study from Vanuatu.
    Carroll KJ; Carroll C
    J Trop Med Hyg; 1994 Jun; 97(3):145-50. PubMed ID: 8007054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early neurologic complications and long-term sequelae of childhood bacterial meningitis in a limited-resource country (Kosovo).
    Namani SA; Koci BM; Milenković Z; Koci R; Qehaja-Buçaj E; Ajazaj L; Mehmeti M; Ismaili-Jaha V
    Childs Nerv Syst; 2013 Feb; 29(2):275-80. PubMed ID: 22968209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Should corticosteroids be used in bacterial meningitis in children?
    Esposito S; Semino M; Picciolli I; Principi N
    Eur J Paediatr Neurol; 2013 Jan; 17(1):24-8. PubMed ID: 22789668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children.
    Scholz H; Hofmann T; Noack R; Edwards DJ; Stoeckel K
    Chemotherapy; 1998; 44(2):142-7. PubMed ID: 9551246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children.
    Karageorgopoulos DE; Valkimadi PE; Kapaskelis A; Rafailidis PI; Falagas ME
    Arch Dis Child; 2009 Aug; 94(8):607-14. PubMed ID: 19628879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Slow initial β-lactam infusion and oral paracetamol to treat childhood bacterial meningitis: a randomised, controlled trial.
    Pelkonen T; Roine I; Cruzeiro ML; Pitkäranta A; Kataja M; Peltola H
    Lancet Infect Dis; 2011 Aug; 11(8):613-21. PubMed ID: 21550313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dexamethasone decreases cerebrospinal fluid soluble tumor necrosis factor receptor 1 levels in bacterial meningitis.
    Ichiyama T; Matsushige T; Kajimoto M; Tomochika K; Matsubara T; Furukawa S
    Brain Dev; 2008 Feb; 30(2):95-9. PubMed ID: 17664049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Corticosteroids and bacterial meningitis.
    Kaplan SL
    Scand J Infect Dis Suppl; 1990; 73():43-54. PubMed ID: 2091256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group.
    Klugman KP; Dagan R
    Antimicrob Agents Chemother; 1995 May; 39(5):1140-6. PubMed ID: 7625802
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beneficial effects of dexamethasone in children with pneumococcal meningitis.
    Kanra GY; Ozen H; Seçmeer G; Ceyhan M; Ecevit Z; Belgin E
    Pediatr Infect Dis J; 1995 Jun; 14(6):490-4. PubMed ID: 7667053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.